Published in Am J Psychiatry on July 01, 2000
Abstinence from chronic cocaine self-administration alters striatal dopamine systems in rhesus monkeys. Neuropsychopharmacology (2008) 1.67
Positron emission tomography quantification of serotonin transporter in suicide attempters with major depressive disorder. Biol Psychiatry (2013) 1.07
Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder. Pharmacol Rev (2015) 1.06
Depression research: where are we now? Mol Brain (2010) 1.06
Alterations in tryptophan and purine metabolism in cocaine addiction: a metabolomic study. Psychopharmacology (Berl) (2009) 1.05
Reduced forebrain serotonin transmission is causally involved in the development of compulsive cocaine seeking in rats. Neuropsychopharmacology (2012) 0.93
Dopamine transporter levels in cocaine dependent subjects. Drug Alcohol Depend (2008) 0.89
Recent advances in imaging of dopaminergic neurons for evaluation of neuropsychiatric disorders. J Biomed Biotechnol (2012) 0.87
Striatal dopamine transporter availability with [123I]beta-CIT SPECT is unrelated to gender or menstrual cycle. Psychopharmacology (Berl) (2005) 0.86
Effects of cocaine and MDMA self-administration on serotonin transporter availability in monkeys. Neuropsychopharmacology (2007) 0.86
Serotonin and mental disorders: a concise review on molecular neuroimaging evidence. Clin Psychopharmacol Neurosci (2014) 0.84
123I-ADAM SPECT imaging of serotonin transporter binding in patients with night eating syndrome: a preliminary report. Psychiatry Res (2008) 0.84
Monoamine transporter inhibitors and substrates as treatments for stimulant abuse. Adv Pharmacol (2014) 0.84
Imaging receptor changes in human drug abusers. Curr Top Behav Neurosci (2010) 0.83
Differential effects of cocaine and MDMA self-administration on cortical serotonin transporter availability in monkeys. Neuropharmacology (2011) 0.82
Impulse control disorders in Parkinson's disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry (2013) 0.82
Pharmacotherapy for stimulant-related disorders. Curr Psychiatry Rep (2013) 0.82
Aripiprazole effects on self-administration and pharmacodynamics of intravenous cocaine and cigarette smoking in humans. Exp Clin Psychopharmacol (2014) 0.80
Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy. Biol Psychiatry (2013) 0.80
SPECT imaging with the serotonin transporter radiotracer [123I]p ZIENT in nonhuman primate brain. Nucl Med Biol (2010) 0.77
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
MRI-based measurement of hippocampal volume in patients with combat-related posttraumatic stress disorder. Am J Psychiatry (1995) 5.34
Substance use disorders in patients with posttraumatic stress disorder: a review of the literature. Am J Psychiatry (2001) 3.69
Magnetic resonance imaging-based measurement of hippocampal volume in posttraumatic stress disorder related to childhood physical and sexual abuse--a preliminary report. Biol Psychiatry (1997) 3.39
Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proc Natl Acad Sci U S A (1996) 3.28
Rapid and ultrarapid opioid detoxification techniques. JAMA (1998) 3.16
Neurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychopharmacology (1998) 2.96
A randomized controlled trial of auricular acupuncture for cocaine dependence. Arch Intern Med (2000) 2.87
A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. Am J Med (1998) 2.37
Evaluation of ultrafiltration for the free-fraction determination of single photon emission computed tomography (SPECT) radiotracers: beta-CIT, IBF, and iomazenil. J Pharm Sci (1994) 2.31
Increased striatal dopamine transmission in schizophrenia: confirmation in a second cohort. Am J Psychiatry (1998) 2.30
Reduced brain serotonin transporter availability in major depression as measured by [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane and single photon emission computed tomography. Biol Psychiatry (1998) 2.03
Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry (2011) 2.03
Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse. Arch Gen Psychiatry (1997) 1.99
Three methods of opioid detoxification in a primary care setting. A randomized trial. Ann Intern Med (1997) 1.87
Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry (2000) 1.82
Deficits in short-term memory in posttraumatic stress disorder. Am J Psychiatry (1993) 1.81
A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet (2001) 1.80
Distinct cholecystokinin receptors in brain and pancreas. Proc Natl Acad Sci U S A (1980) 1.78
Age-related decline in striatal dopamine transporter binding with iodine-123-beta-CITSPECT. J Nucl Med (1995) 1.77
Imaging the function of P-glycoprotein with radiotracers: pharmacokinetics and in vivo applications. Clin Pharmacol Ther (2009) 1.77
Should protracted withdrawal from drugs be included in DSM-IV? Am J Psychiatry (1993) 1.71
Concurrent validity of the addiction severity index. J Nerv Ment Dis (1983) 1.68
5-Iodo-A-85380, an alpha4beta2 subtype-selective ligand for nicotinic acetylcholine receptors. Mol Pharmacol (2000) 1.67
Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry (1986) 1.62
SPECT imaging of striatal dopamine release after amphetamine challenge. J Nucl Med (1995) 1.56
Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial. Biol Psychiatry (2000) 1.55
Immunocytochemical localization of the dopamine transporter in human brain. J Comp Neurol (1999) 1.55
Prediction of dopamine transporter binding availability by genotype: a preliminary report. Am J Psychiatry (2000) 1.54
Gender differences in cocaine use and treatment response. J Subst Abuse Treat (1993) 1.50
Imaging D2 receptor occupancy by endogenous dopamine in humans. Neuropsychopharmacology (1997) 1.50
Disulfiram effects on acute cocaine administration. Drug Alcohol Depend (1998) 1.50
Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse (2001) 1.48
SPECT imaging of the benzodiazepine receptor: feasibility of in vivo potency measurements from stepwise displacement curves. J Nucl Med (1991) 1.47
A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry (2000) 1.44
Treatment of cocaine abuse with mazindol. Lancet (1989) 1.43
SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates. Synapse (1993) 1.41
Rapid detoxification from opioid dependence. Am J Psychiatry (1989) 1.40
Concurrent use of cocaine and alcohol is more potent and potentially more toxic than use of either alone--a multiple-dose study. Biol Psychiatry (1998) 1.40
Peptide neurotransmitters. Annu Rev Biochem (1979) 1.35
Urinary free-cortisol levels in posttraumatic stress disorder patients. J Nerv Ment Dis (1986) 1.35
Day treatment versus enhanced standard methadone services for opioid-dependent patients: a comparison of clinical efficacy and cost. Am J Psychiatry (1999) 1.34
Nicotine dependence and schizophrenia. Hosp Community Psychiatry (1994) 1.32
Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc Natl Acad Sci U S A (1979) 1.32
Vaccines against drug abuse. Clin Pharmacol Ther (2011) 1.32
Positron emission tomography measurement of cerebral metabolic correlates of yohimbine administration in combat-related posttraumatic stress disorder. Arch Gen Psychiatry (1997) 1.31
Quantitative morphology of the caudate and putamen in patients with cocaine dependence. Am J Psychiatry (2001) 1.30
The variable number of tandem repeats polymorphism of the dopamine transporter gene is not associated with significant change in dopamine transporter phenotype in humans. Neuropsychopharmacology (2001) 1.28
Single photon emission computed tomographic imaging demonstrates loss of striatal dopamine transporters in Parkinson disease. Proc Natl Acad Sci U S A (1993) 1.27
Immunochemical analysis of dopamine transporter protein in Parkinson's disease. Ann Neurol (1997) 1.27
Psychiatric disorders in relatives of probands with opiate addiction. Arch Gen Psychiatry (1991) 1.26
D2 receptors binding potential is not affected by Taq1 polymorphism at the D2 receptor gene. Mol Psychiatry (1998) 1.26
[123I] beta-CIT/SPECT imaging demonstrates bilateral loss of dopamine transporters in hemi-Parkinson's disease. Neurology (1996) 1.24
Microdialysis and SPECT measurements of amphetamine-induced dopamine release in nonhuman primates. Synapse (1997) 1.23
Iodine-123-beta-CIT and iodine-123-FPCIT SPECT measurement of dopamine transporters in healthy subjects and Parkinson's patients. J Nucl Med (1998) 1.22
Noradrenergic dysregulation during discontinuation of cocaine use in addicts. Arch Gen Psychiatry (1994) 1.22
Ethnic and gender differences among opiate addicts. Int J Addict (1985) 1.22
Graphical, kinetic, and equilibrium analyses of in vivo [123I] beta-CIT binding to dopamine transporters in healthy human subjects. J Cereb Blood Flow Metab (1994) 1.21
Pathological gambling. JAMA (2001) 1.21
[3H]Bradykinin receptor binding in mammalian tissue membranes. Proc Natl Acad Sci U S A (1981) 1.21
Office-based treatment for opioid dependence: reaching new patient populations. Am J Psychiatry (2001) 1.21
Decreased benzodiazepine receptor binding in prefrontal cortex in combat-related posttraumatic stress disorder. Am J Psychiatry (2000) 1.20
Elevated striatal dopamine transporters during acute cocaine abstinence as measured by [123I] beta-CIT SPECT. Am J Psychiatry (1998) 1.19
Physiological basis for BOLD MR signal changes due to neuronal stimulation: separation of blood volume and magnetic susceptibility effects. Magn Reson Med (1998) 1.19
Desipramine facilitation of initial cocaine abstinence. Arch Gen Psychiatry (1989) 1.19
Prognostic factors in Buprenorphine- versus methadone-maintained patients. J Nerv Ment Dis (1998) 1.17
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients. Drug Alcohol Depend (1995) 1.17
Contingency management interventions: from research to practice. Am J Psychiatry (2001) 1.17
A 2.5-year follow-up of cocaine use among treated opioid addicts. Have our treatments helped? Arch Gen Psychiatry (1987) 1.16
Concurrent cocaine-ethanol ingestion in humans: pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology (Berl) (1993) 1.15
SPECT [I-123]iomazenil measurement of the benzodiazepine receptor in panic disorder. Biol Psychiatry (2000) 1.15
Dopamine D2 receptors in the cerebral cortex: distribution and pharmacological characterization with [3H]raclopride. Proc Natl Acad Sci U S A (1989) 1.15